Skip to main content
Premium Trial:

Request an Annual Quote

Response Biomedical's Q2 Revenues Slide 18 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Biomedical today reported an 18 percent drop in total revenues for the second quarter as contract service fees and revenues from collaborative research arrangements took a 79 percent hit.

For the three months ended June 30, the company posted revenues of $2.3 million, down from $2.7 million a year ago, while contract service fees and collaborative research-based revenues dropped to $143,089 from $668,221 in Q2 2009.

Product revenues rose 2 percent year over year to a little more than $2.1 million from just under $2.1 million as revenues from clinical products climbed to nearly $2 million, up 10 percent from $1.8 million a year ago, driven by "strong demand" in China for the company's cardiac products, said company CEO Wayne Kay in a statement.

"We expect to focus resources during the second half of the year on supporting this market expansion in China and other international markets for our cardiac portfolio," he said.

For the quarter, Response Biomedical said that its net loss was flat at $1.9 million, or $0.07 per share, from $1.9 million, or $0.09 per share in Q2 2009.

Response Biomedical said it had $543,617 in cash and cash equivalents as of June 30.

Two weeks ago, the company announced it had closed on a C$8 million ($7.7 million) private placement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.